Executive Summary / Key Takeaways
- The two-year SCI Direct transition from trust-funded to insurance-funded preneed contracts is now complete, removing a headwind that suppressed 2025 sales production and setting up low-to-mid single digit growth in 2026, with higher-value contracts maturing from the backlog to drive margin expansion.
- SCI's $17 billion preneed backlog functions as a massive interest-free float, providing unmatched revenue visibility and funding disciplined capital allocation that returned $645 million to shareholders in 2025 while simultaneously investing $101 million in accretive acquisitions.
- Demographic tailwinds from the aging baby boomer generation will drive funeral volume growth starting in 2027-2028, while the cremation rate moderates near 65%, limiting its drag on average revenue per service and positioning SCI to capture premium memorialization opportunities.
- The company's fortress balance sheet, anchored by a new $2.5 billion credit facility and leverage at the low end of its 3.5x-4.0x target range, provides firepower for continued consolidation in a fragmented industry where high barriers to entry protect incumbent positions.
- The primary risk to the 8-12% long-term EPS growth framework is continued softness in funeral volumes, which management acknowledges could push results to the lower end of 2026 guidance if declines exceed 200 basis points, making volume stabilization the critical variable to monitor.
Setting the Scene: Deathcare's Consolidation King
Service Corporation International, incorporated in Texas in July 1962 and headquartered in Houston, has spent six decades building what is now North America's largest deathcare network. The company operates 1,485 funeral service locations and 500 cemeteries across 44 U.S. states, eight Canadian provinces, the District of Columbia, and Puerto Rico, commanding approximately 18% of the North American market. This scale is the foundation of SCI's economic moat, enabling procurement efficiencies, shared overhead across location clusters, and a preneed sales machine that smaller competitors cannot replicate.
SCI generates revenue through two primary segments: Funeral Operations (55.7% of 2025 revenue) and Cemetery Operations (44.1%). The funeral segment provides professional services and merchandise for both traditional burials and cremations, while the cemetery segment sells interment rights, markers, and related services. The average revenue per cremation service remains lower than traditional burial, but SCI is actively developing memorialization products specifically for cremation customers to capture incremental value. The significance lies in the cremation rate reaching 64.4% in 2025, up 50 basis points year-over-year, and management expects future increases to be modest—less than 100 basis points annually—as the rate approaches its natural ceiling. This moderation limits the headwind on blended average revenue per service, allowing pricing power to flow through more directly.
The deathcare industry structure fundamentally favors SCI. Funeral homes have low-to-moderate barriers to entry, but cemeteries face high barriers due to land scarcity, permitting requirements, and capital intensity. SCI controls 35,000 acres of cemetery property, much of it in metropolitan areas with decades of remaining capacity. This real estate moat creates pricing power and limits competitive encroachment. The industry remains highly fragmented, with thousands of locally-owned independents competing against SCI's Dignity Memorial brand, North America's first transcontinental deathcare brand. This brand portability allows families to transfer preneed contracts across locations—a unique value proposition that drives customer loyalty and reduces price sensitivity.
Industry drivers are aligning favorably. The aging baby boomer generation will begin materially impacting death rates in the late 2020s, with models forecasting volume increases starting in 2027-2028. Post-COVID normalization is now complete, with excess deaths from drug overdoses, suicides, traffic fatalities, and murders all trending down, and cancer screenings returning to normal levels. This normalization clears the noise from pandemic-related volatility, allowing focus on underlying demographic trends. The demographic wave is a visible pipeline of demand that will begin flowing through SCI's network within the next two to three years.
Technology, Products, and Strategic Differentiation: The Preneed Float Engine
SCI's core competitive advantage lies in its preneed sales strategy and the massive backlog it generates. As of December 31, 2025, the company held $17.01 billion in deferred revenue, up from $16.01 billion a year prior. This backlog functions as an interest-free float—customers pay today for services that may not be delivered for decades, while SCI invests these funds in trust accounts and earns investment income. In 2025, recognized trust fund income from preneed investments totaled $202.2 million, up from $185.7 million in 2024. This income stream provides stability during volume fluctuations and funds capital returns without compromising operational flexibility.
The recent strategic pivot from trust-funded to insurance-funded preneed contracts for the SCI Direct segment represents a critical evolution of this model. The transition, which began in mid-2024 and reached 100% completion by Q4 2025, required extensive training and licensing for 3,800 sales counselors. This process was challenging, as non-funeral home preneed sales production declined 26% in Q1 2025, 14% in Q2, and almost 20% in Q3 as counselors adapted to the new product. This matters because the insurance model improves cash flow dynamics. Insurance-funded contracts generate immediate general agency commission recognition, while trust-funded products defer revenue recognition. This shift explains why general agency revenue surged to $292.1 million in 2025 from $230.9 million in 2024, and why management expects the commission rate to stabilize in the mid-30s percentage range moving forward.
The immediate recognition of lower-margin general agency commissions initially pressured SCI Direct's margins, replacing high-margin merchandise revenues with lower-margin commission income. However, this is a temporary accounting artifact. The insurance product offers consumers better protection and portability, leading to higher-value contracts that will mature from the backlog over time. While it will take a couple of years to return to pre-transition sales levels, the long-term value creation is significant. For investors, this means 2025 represented the trough of disruption, and 2026 marks the beginning of renewed growth.
Beyond the financial mechanics, SCI is innovating its product offerings to capture changing consumer preferences. The company is piloting and rolling out cremation-specific marketing in cemeteries, including videos showcasing cremation memorialization options like gardens and niches. This addresses the reality that cremation customers have historically been less likely to purchase cemetery property. By creating compelling memorialization products, SCI can drive incremental revenue from a growing segment. The company is also repurposing traditional casket selection rooms into event spaces for "celebration of life" ceremonies, reflecting the cultural shift from solemn mourning to personalized services. These adaptations expand addressable revenue per customer and defend against low-cost cremation providers.
Digital strategy is another differentiator. SCI is investing $25 million annually in digital capabilities, including search engine optimization and online tribute platforms. These investments improve lead generation and conversion rates, directly impacting preneed sales productivity. The company's cross-functional margin improvement committee disseminates best practices across its portfolio, leveraging scale to drive operational efficiency. This approach to margin expansion—proactive staffing management, daily dashboards, and overtime controls—generated 210 basis points of funeral gross margin improvement in Q2 2025 and 240 basis points in Q1. This demonstrates that margin expansion is not just a function of pricing but of systematic operational leverage.
Financial Performance & Segment Dynamics: Evidence of Strategic Execution
SCI's 2025 financial results validate the strategic pivot and operational improvements. Consolidated revenue reached $4.31 billion, with funeral revenue growing 3.5% to $2.405 billion and cemetery revenue growing 2.2% to $1.904 billion. More importantly, funeral gross profit increased 6.6% to $495.77 million, expanding margins by 60 basis points despite a 0.8% decline in comparable services performed. This divergence—profit growing faster than revenue while volumes decline—proves that pricing power and cost management are working. The cremation mix shift, which typically pressures revenue, was partially offset by a 2.9% increase in average revenue per service, demonstrating SCI's ability to extract value through premium services and merchandise.
The cemetery segment delivered equally impressive margin expansion. Gross profit grew 3.0% to $644.31 million, with the gross margin percentage increasing despite a challenging Q1 where recognized preneed property revenue declined $12 million due to lower sales production and recognition rates. By Q4, cemetery gross profit margins exceeded 36%, driven by a $8 million increase in endowment care trust fund income and disciplined cost management. This volatility in large property sales creates quarterly lumpiness but does not detract from the segment's underlying health. For the full year, preneed cemetery sales production grew 4%, and the segment is poised for continued growth as demographic tailwinds strengthen.
Cash flow generation remains the cornerstone of SCI's investment case. Operating cash flow reached $942.8 million in 2025, with adjusted operating cash flow of $966 million. Free cash flow of $554.25 million funded $645 million in shareholder returns through $461 million in share repurchases (5.86 million shares at $79.15 average cost) and $184 million in dividends. The company also invested $101 million in acquisitions comprising 22 funeral service locations and 2 cemeteries, plus $18.5 million in real estate. This capital allocation pattern—returning more cash to shareholders than the entire free cash flow while simultaneously funding growth investments—demonstrates the power of the preneed float. The $17 billion backlog provides a source of financing that allows SCI to be aggressive on capital returns without compromising balance sheet strength.
The balance sheet is robust. In November 2025, SCI entered into a new $2.5 billion bank credit agreement maturing in November 2030, replacing existing facilities and increasing liquidity by over $350 million. Current liquidity stands at approximately $1.7 billion, with a leverage ratio of 3.65x net debt to EBITDA at the low end of the 3.5x-4.0x target range. This provides dry powder for larger acquisitions as the industry consolidates. Management's acquisition strategy prioritizes markets where SCI already has presence to achieve synergies, and the new credit facility enables this local density strategy at scale.
Segment-level performance reveals important mix shifts. Funeral preneed sales production increased 11% in Q4 2025, with core preneed up 12% and non-funeral home (SCI Direct) up 8%. This acceleration occurred despite the transition headwinds, indicating that the underlying demand for preneed planning is strengthening. General agency revenue from insurance-funded contracts surged $8 million in Q4, which helped mitigate the $6 million reduction in merchandise delivery revenue from the decision to defer urn delivery. This accounting shift—recognizing commission income immediately while deferring merchandise revenue—creates temporary margin pressure but improves cash flow velocity. SCI is optimizing for cash economics over reported margins in the short term, a trade-off that enhances long-term value creation.
Outlook, Management Guidance, and Execution Risk
SCI's 2026 guidance frames a compelling growth narrative. Management projects adjusted EPS of $4.05 to $4.35, representing 5% to 13% growth with a 9% midpoint. This aligns with the company's long-term framework of 8% to 12% EPS growth, which management believes it can achieve with 85% to 90% confidence in a typical year. The guidance assumes funeral volumes will be flat to slightly down compared to 2025, with average revenue per case growing at inflationary rates, slightly offset by modest cremation mix increases. This conservative volume assumption sets a low bar for outperformance. If demographic trends accelerate or cremation rates stabilize faster than expected, volume upside could drive meaningful earnings leverage.
The funeral segment outlook hinges on three factors: preneed sales growth, margin expansion, and SCI Direct stabilization. Management expects preneed funeral production to grow in the low-to-mid single-digit percentage range for both core and SCI Direct businesses. This represents a significant inflection from 2025's declines. The insurance product rollout is now 100% complete, and management expects a positive trend year-over-year for SCI Direct starting in early 2026. The commission rate is expected to stabilize in the mid-30s percentage range, removing a source of Q4 2025 volatility. Fixed costs are expected to be managed slightly below inflationary levels, driving gross margin percentage expansion of 20 to 60 basis points. This operational leverage demonstrates that margin expansion is not dependent on volume growth but on systematic cost discipline.
The cemetery segment offers a compelling growth trajectory. Management anticipates preneed cemetery sales production will grow in the low-to-mid single-digit percentage range, resulting in revenue growth of 2% to 5%. This acceleration from 2025's 2.2% growth reflects both demographic tailwinds and strategic initiatives. The company is investing approximately $165 million in high-return cemetery development projects, creating tiered inventory options from private mausoleums to semi-private areas. This capital deployment targets low-to-mid-teen after-tax internal rates of return, well above the cost of capital. The focus on cremation consumers—piloting videos and increased visibility of cremation memorialization options—addresses the fastest-growing segment and could unlock incremental revenue from customers who previously bypassed cemetery purchases.
Below the line, management expects a net favorable impact on EPS from lower share count, partially offset by higher interest expense and a slightly higher tax rate. Cash taxes are projected to decline $20 million to $120 million in 2026 due to an anticipated tax benefit from renewable energy investments, though a normalized rate of 24% to 25% is expected beyond 2026. This temporary tax benefit provides a $0.10-$0.15 EPS tailwind in 2026, enhancing the achievability of guidance. The company plans to maintain maintenance capital expenditures at approximately $325 million, with $135 million allocated to funeral homes and cemeteries, $165 million to cemetery development, and $25 million to digital strategy. This disciplined capex framework ensures that growth investments are funded while excess cash flows to shareholders.
Execution risk centers on volume trends and SCI Direct recovery. Management has noted that continued soft funeral volumes could put the company at the lower end of EPS guidance, specifically identifying that a 200 basis point decline would be difficult to overcome. This identifies the key variable for investors to monitor. Conversely, strong preneed sales activity, positive SCI Direct trends, and effective expense management could drive results to the higher end. The 85% to 90% confidence level management assigns to its 8-12% long-term growth framework suggests high visibility, but investors should watch Q1 2026 SCI Direct sales trends as an early indicator of success.
Risks and Asymmetries: What Could Break the Thesis
The most material risk is a sustained decline in funeral volumes beyond management's expectations. While demographic tailwinds are visible on the horizon, the timing remains uncertain. If volumes decline 2% or more in 2026, the resulting deleverage on fixed costs could compress margins and challenge the EPS growth framework. This risk is amplified by the cremation mix shift, which reduces average revenue per service. Although management expects cremation rate increases to moderate, any acceleration could pressure revenue growth and margin expansion. The company's ability to offset volume declines with pricing and cost management has been demonstrated in 2025, but there are limits to this flexibility.
Trust fund performance represents a latent risk. With $17 billion in preneed contracts funded by trust investments, a significant market decline could create a coverage shortfall. If the investments in trust funds experience significant declines or in a high inflation environment, there could be insufficient funds in the trusts to cover the costs of delivering merchandise and services. This would require SCI to cover shortfalls with operating cash flow, impacting financial condition. While the company has historically earned stable trust income, a severe recession or prolonged bear market could test this assumption. The risk is mitigated by diversified trust allocations and the long-term nature of obligations, but it remains a tail risk that could impair liquidity.
The SCI Direct transition, while complete, still carries execution risk. The change required extensive training and licensing, and turnover in the sales force has impacted production. While 100% of locations have transitioned, sales levels remain below pre-transition peaks. If the expected year-over-year growth in early 2026 fails to materialize, or if the sales force takes longer than anticipated to return to full productivity, the funeral segment's growth trajectory could be compromised. The commission rate volatility observed in Q4 2025—where core general agency revenue declined 13% due to product mix changes and higher cancellations—demonstrates that the new insurance partner relationship requires ongoing optimization.
Inflation and consumer discretionary spending present a nuanced risk. While deathcare services are less sensitive to economic downturns than true discretionary categories, persistent inflation could pressure margins if cost increases outpace pricing power. The company sources approximately 60% of merchandise domestically, mitigating tariff risk, but wage inflation in a tight labor market could impact the sales force and operational staffing. Management's focus on labor efficiency through daily dashboards and proactive staffing management addresses this, but sustained inflation above pricing power would compress margins.
Cybersecurity and AI risks are emerging threats. The increasing sophistication of cyberattacks could compromise customer data or disrupt operations, while AI technologies could produce inaccurate outputs or be improperly used by employees. SCI has established an AI Governance and Advisory Committee to guide adoption, but the rapid evolution of these technologies creates uncertainty. The risk is amplified by the company's digital transformation initiatives and online preneed sales platforms. A significant data breach could damage the trusted brand that is central to preneed sales success.
On the positive side, several asymmetries could drive upside. If demographic tailwinds accelerate faster than expected, funeral volumes could turn positive earlier than the 2027-2028 timeframe, creating significant operating leverage. The cemetery development pipeline could generate higher returns if land values appreciate or if premium products like private mausoleums gain traction. The insurance-funded preneed model may prove more valuable than anticipated, with higher persistency and larger average contract sizes boosting general agency revenue beyond the mid-30s commission rate. Finally, industry consolidation could accelerate, allowing SCI to deploy its $1.7 billion in liquidity for transformative acquisitions at attractive multiples.
Valuation Context
At $75.85 per share, SCI trades at 19.96 times trailing earnings and 11.82 times EV/EBITDA. The price-to-free-cash-flow ratio of 19.18 and price-to-operating-cash-flow ratio of 11.28 reflect a company generating substantial cash conversion. With an enterprise value of $15.61 billion and revenue of $4.31 billion, the EV/Revenue multiple of 3.62 sits between high-growth software and traditional service businesses, appropriate for a company with SCI's unique combination of stability and growth.
Relative to peers, SCI commands a premium that is justified by its scale and market position. Carriage Services (CSV) trades at 12.95 times earnings and 9.97 times EV/EBITDA, but generates only $60.7 million in operating cash flow compared to SCI's $942.8 million. Matthews International (MATW) trades at 34.45 times earnings but is unprofitable on a net income basis with negative operating cash flow. Security National Financial (SNFCA) trades at 7.41 times earnings but operates a fraction of SCI's scale with heavy mortgage diversification. SCI's return on equity of 32.73% compares favorably to CSV's 22.23% and SNFCA's 8.12%, demonstrating superior capital efficiency.
The dividend yield of 1.79% with a 34.21% payout ratio provides income while retaining substantial cash for growth. The company's aggressive share repurchase program—reducing share count by 2.8% in 2025 alone—accelerates EPS growth and signals management's confidence in valuation. With a beta of 1.00, SCI offers market-like volatility with defensive characteristics, as deathcare demand is non-cyclical. The debt-to-equity ratio of 3.18 is elevated but manageable within the company's leverage target, and the new $2.5 billion credit facility provides ample liquidity for strategic flexibility.
Valuation multiples must be considered in the context of the $17 billion preneed backlog, which is not fully reflected on the balance sheet but represents a contracted revenue stream that will convert over decades. This float effectively reduces enterprise value by providing a source of interest-free financing, making the apparent EV/EBITDA multiple more attractive than it appears. The company's ability to generate $554 million in free cash flow while returning $645 million to shareholders demonstrates that the backlog functions as a working capital benefit, funding capital returns without impairing growth investments.
Conclusion
Service Corporation International has successfully navigated a critical transition year, completing the SCI Direct shift to insurance-funded preneed contracts while maintaining operational momentum and returning substantial capital to shareholders. The completion of this transition removes a headwind that suppressed 2025 growth and positions the company for low-to-mid single digit preneed sales expansion in 2026. More importantly, it unlocks the full power of SCI's preneed float engine—the $17 billion backlog that provides unmatched revenue visibility and funds disciplined capital allocation.
The investment thesis hinges on two interlocking drivers: demographic tailwinds from aging baby boomers that will accelerate funeral volumes starting in 2027-2028, and operational leverage from the completed SCI Direct transition that will drive margin expansion even before volumes inflect. Management's 8-12% long-term EPS growth framework, supported by 85-90% confidence in a typical year, is credible given the company's demonstrated ability to grow average revenue per service, expand margins through cost discipline, and allocate capital accretively. The 2026 guidance midpoint of 9% EPS growth, combined with a $20 million tax benefit and continued share repurchases, provides a clear path to delivering on this framework.
The key variables to monitor are funeral volume trends and SCI Direct sales recovery. If volumes stabilize at flat to slightly down levels, the pricing power and cost management demonstrated in 2025 will drive margin expansion and EPS growth. If SCI Direct achieves year-over-year growth in early 2026 as management expects, it will confirm that the insurance-funded model is gaining traction and that the sales force has adapted. Conversely, if volumes decline more than 200 basis points or SCI Direct sales remain sluggish, the thesis could be challenged. For now, SCI's unmatched scale, fortress balance sheet, and proven capital allocation discipline position it to compound shareholder value as the demographic wave approaches.
